Nephron and Clemson to Develop Robotics for Syringe Filling
Nephron Pharmaceuticals is partnering with Clemson University to create a robotic solution for syringe-filling automation to enhance sterile manufacturing.
Nephron Pharmaceuticals Corporation, which is based in West Columbia, SC, announced on Aug. 12, 2019, that the company is partnering with Clemson University to create a robotic solution for syringe-filling automation. The robotics research is being done to enhance sterile manufacturing to keep up with supply demand. The technology will support the Nephron 503B Outsourcing Facility, a cGMP manufacturer providing sterile, prefilled medications.
The partnership is Nephron's first with the University and was developed through External Affairs' Office of Corporate Partnerships and Strategic Initiatives at Clemson. "Industry needs are changing at a rapid rate, and Clemson is equipped to support companies like Nephron. Together, we have created a mutually beneficial project to enhance their capabilities while providing the University's students with unique, hands-on research experience," said Angie Leidinger, vice-president for External Affairs, in the press release.
Clemson College of Engineering, Computing, and Applied Science professor and researcher Yue "Sophie" Wang, mechanical engineering doctoral student Brandon Delspina, and mechanical engineering master's student Yu "Gloria" Zhang are performing the robotics research.
Source: Nephron
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
